MOH — authorised 26 May 1953
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
🇮🇱 Thyrogen in Israel
MOH authorised Thyrogen on 26 May 1953
Marketing authorisation
Thyrogen in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Thyrogen approved in Israel?
Yes. MOH authorised it on 26 May 1953.
Who is the marketing authorisation holder for Thyrogen in Israel?
SANOFI AVENTIS US holds the Israeli marketing authorisation.